Sophie Stotz, Gina Dunkel, Sabrina Haas, Philipp Seyfried, Johannes Kinzler, Jacqueline Berner, Martin Schaller, Michael Lämmerhofer, Seth G N Grant, Bernd J Pichler, Bettina Weigelin, Kristina Herfert, Andreas Maurer
{"title":"A PET reporter ligand for quantitative imaging of gene expression in the brain.","authors":"Sophie Stotz, Gina Dunkel, Sabrina Haas, Philipp Seyfried, Johannes Kinzler, Jacqueline Berner, Martin Schaller, Michael Lämmerhofer, Seth G N Grant, Bernd J Pichler, Bettina Weigelin, Kristina Herfert, Andreas Maurer","doi":"10.1038/s41551-026-01748-x","DOIUrl":null,"url":null,"abstract":"<p><p>The lack of brain penetrant and biologically stable positron emission tomography reporter systems hampers the development of neurological disease models and the monitoring of gene delivery because existing approaches depend on endogenous receptors that vary unpredictably in pathology. HaloTag, a fully exogenous protein label that forms rapid and irreversible bonds with synthetic ligands, provides a modular platform for engineering reporter probes with defined chemical properties. Here we developed a fluorine-18-labelled small-molecule HaloTag ligand optimized for brain entry and covalent retention at the reporter. The tracer showed specific binding in human cells expressing HaloTag and enabled non-invasive imaging of viral gene transfer to striatal neurons in mice, with clear detection of reporter expressing tissue and rapid clearance from surrounding regions. Optical imaging confirmed viral distribution and reporter expression, and a transgenic model expressing HaloTag fused to a postsynaptic protein demonstrated detection of physiologically expressed intraneuronal targets. This system establishes a modular platform for validating preclinical models and quantifying gene expression in the living brain.</p>","PeriodicalId":19063,"journal":{"name":"Nature Biomedical Engineering","volume":" ","pages":""},"PeriodicalIF":26.3000,"publicationDate":"2026-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Biomedical Engineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1038/s41551-026-01748-x","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
The lack of brain penetrant and biologically stable positron emission tomography reporter systems hampers the development of neurological disease models and the monitoring of gene delivery because existing approaches depend on endogenous receptors that vary unpredictably in pathology. HaloTag, a fully exogenous protein label that forms rapid and irreversible bonds with synthetic ligands, provides a modular platform for engineering reporter probes with defined chemical properties. Here we developed a fluorine-18-labelled small-molecule HaloTag ligand optimized for brain entry and covalent retention at the reporter. The tracer showed specific binding in human cells expressing HaloTag and enabled non-invasive imaging of viral gene transfer to striatal neurons in mice, with clear detection of reporter expressing tissue and rapid clearance from surrounding regions. Optical imaging confirmed viral distribution and reporter expression, and a transgenic model expressing HaloTag fused to a postsynaptic protein demonstrated detection of physiologically expressed intraneuronal targets. This system establishes a modular platform for validating preclinical models and quantifying gene expression in the living brain.
期刊介绍:
Nature Biomedical Engineering is an online-only monthly journal that was launched in January 2017. It aims to publish original research, reviews, and commentary focusing on applied biomedicine and health technology. The journal targets a diverse audience, including life scientists who are involved in developing experimental or computational systems and methods to enhance our understanding of human physiology. It also covers biomedical researchers and engineers who are engaged in designing or optimizing therapies, assays, devices, or procedures for diagnosing or treating diseases. Additionally, clinicians, who make use of research outputs to evaluate patient health or administer therapy in various clinical settings and healthcare contexts, are also part of the target audience.